Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Single-use infusion device testing is a mandatory quality control and regulatory conformity process that verifies the safety, performance, and sterility of disposable infusion sets, transfusion sets, syringes, and related administration equipment. This article provides a comprehensive technical overview of applicable standards, sample types, physical, chemical, and biological test items, testing methodologies, and practical applications in medical device manufacturing and registration.

Single-Use Infusion Device Testing: Standards, Test Items, Methods, and Applications

Technical Overview

Single-use infusion devices are sterile, disposable medical products that come into direct contact with injectable fluids, blood, and patient tissue. This category primarily includes gravity infusion sets, pressure infusion sets for infusion pumps, blood transfusion sets, sterile hypodermic syringes, injection needles, extension tubes, and their accessory components. Because failure of these devices can directly endanger patient life, manufacturers and regulators require systematic inspection covering physical performance, chemical safety, biological compatibility, sterility, and packaging integrity.

Testing is conducted against a framework of national and international standards. In the Chinese market, the core product standards include GB 8368 for sterile infusion sets for single use, GB 8369 for sterile blood transfusion sets for single use, GB 15810 for sterile hypodermic syringes, and GB 15811 for sterile hypodermic needles. These are supported by method standards such as GB/T 14233.1 for chemical analysis, GB/T 14233.2 for biological test methods, and GB/T 16886 (identical to ISO 10993) for biological evaluation of medical devices. Internationally, equivalent requirements are specified in ISO 8536-4, ISO 1135-4, and ISO 7886-1.

  • Product standards define design, dimensions, and performance limits for each device type
  • Chemical and biological method standards govern extract preparation and laboratory procedures
  • ISO 10993 and GB/T 16886 establish the biological risk evaluation framework
  • ISO 80369-7 and ISO 594 define conical fitting (luer) interchangeability and securement

Testing Samples

Gravity and Pressure Infusion Sets

Standard gravity-fed infusion sets consist of a spike, drip chamber with dropper, tubing, roller clamp, liquid filter, injection site, and luer connector. Pressure infusion sets intended for use with infusion pumps and volumetric pumps additionally require flow accuracy verification under pump operating conditions, and the tubing must be evaluated for pump-compatibility and resistance to flattening.

Blood Transfusion Sets

Transfusion sets include a blood-taking needle, drip chamber with an integrated blood filter (typically a 200 micrometer mesh), tubing, and connectors. Testing focuses on flow rate with viscous fluids, filter efficiency, and leak resistance under transfusion conditions.

Sterile Syringes and Needles

Hypodermic syringes are tested for graduation accuracy, delivered volume, piston sliding performance, liquid tightness, and residual liquid (dead space). Needles are evaluated for point sharpness, penetration force, stiffness, toughness, and corrosion resistance.

Accessory Components

Sample scope also covers injection needles, needle-free injection sites, stopcocks, extension lines, air inlet devices, and protective caps, all of which must meet connection strength, tightness, and material safety requirements.

Sample Submission Requirements

For type testing and registration, samples must be submitted in final sterile packaging, in a quantity determined by the sampling plan, together with product technical requirements, drawings, material specifications, sterilization method, and validation records.

Testing Items

Physical and Mechanical Performance

  • Appearance and visual defects of tubing, chambers, connectors, and filtration elements
  • Dimensions, including tubing inner diameter, wall thickness, and component length
  • Flow rate with the reservoir maintained 1000 mm above the outlet and the clamp fully open
  • Drip chamber and dropper performance, including drop size consistency and absence of streaming
  • Liquid and air leakage under internal pressure with all connections assembled
  • Connection strength, resistance to axial separation force, and luer fitting conformance
  • Tubing kink resistance and flexibility under bending
  • Liquid filter particle retention and blood filter mesh performance
  • Air inlet device airflow performance and hydrophobic filter integrity
  • Roller clamp flow regulation and closure tightness

Chemical Performance

Chemical testing is performed on a water extract of the device prepared according to GB/T 14233.1, with the following typical determinations:

  • Reducing substances, measured by potassium permanganate consumption of the extract
  • Acidity and alkalinity, determined by acid-base titration of the extract
  • Evaporation residue after drying a measured extract volume
  • Heavy metals content, expressed as lead equivalent
  • Ultraviolet absorbance of the extract across the specified wavelength range
  • Coloration and clarity of the extract against reference solutions
  • Optional determinations such as ammonium, chloride, and zinc depending on product claims

Biological Evaluation

Biological testing follows the GB/T 16886 / ISO 10993 risk-based approach for devices with direct blood or tissue contact and limited exposure duration:

  • In vitro cytotoxicity using the elution method
  • Sensitization by guinea pig maximization or local lymph node assay
  • Intracutaneous reactivity and skin irritation testing
  • Acute systemic toxicity
  • Hemolysis testing, including direct and indirect contact methods
  • Pyrogen testing by the rabbit method or bacterial endotoxin testing by the limulus amebocyte lysate method

Sterility, Endotoxins, and Sterilant Residues

  • Sterility testing or review of sterilization process validation per ISO 11737-1
  • Bacterial endotoxin limits for devices contacting blood or intravenous fluids
  • Ethylene oxide and ethylene chlorohydrin residual levels when ethylene oxide sterilization is used, with residual limits defined in ISO 10993-7 and GB/T 16886.7

Packaging and Labeling

  • Seal strength and integrity of the sterile barrier system
  • Aging resistance and transport simulation of the packaging
  • Completeness and accuracy of labeling, usage instructions, and sterile symbols

Testing Methods

Flow Rate Determination

The device is connected to a water reservoir with the liquid level maintained 1000 mm above the outlet, the flow regulator fully opened, and the collected volume over a defined time interval recorded. Results are compared against the minimum flow rate corresponding to the nominal tubing inner diameter specified in the product standard.

Leak and Pressure Integrity Testing

The assembled device is filled with water, sealed at the distal end, and subjected to the specified internal pressure for a defined hold period while all joints, the drip chamber seal, and the tubing are inspected for liquid or air leakage. Luer connections are additionally assessed for leakage under axial load and for separation force.

Chemical Extraction and Analysis

Test extracts are prepared by immersing the device in purified water under controlled surface-area-to-volume ratio, temperature, and time conditions. Classical titrimetric, gravimetric, and spectrophotometric techniques are then applied to quantify reducing substances, pH shift, evaporation residue, heavy metals, and ultraviolet absorbance against blank controls.

Biological Test Protocols

Biological tests use the same standardized extracts. Cytotoxicity is assessed by exposing cultured mammalian cells to extract dilutions and quantifying viability, while hemocompatibility is evaluated by incubating blood or blood components with the extract or device and measuring hemoglobin release. Results are graded against the acceptance criteria defined in the relevant GB/T 16886 and GB/T 14233.2 test methods.

Sterility and Residual Testing

Sterility is confirmed either through direct sterility testing under pharmacopeial conditions or, more commonly, through documented validation of the sterilization process. Ethylene oxide residuals are determined by headspace gas chromatography of samples taken after the specified aeration period.

Sampling and Batch Release

Statistical sampling plans based on GB/T 2828.1 (ISO 2859-1) are applied for routine batch release, whereas full type testing covering all physical, chemical, and biological items is required for product registration, standard changes, or significant process modifications.

Applications

Manufacturer Quality Control

Device manufacturers apply these tests for incoming material qualification, process validation, routine batch release, and periodic full-spectrum type testing to demonstrate continuing conformity with registered technical requirements.

Regulatory Registration and Market Entry

Test reports issued by accredited laboratories form part of the submission dossier for medical device registration in China under NMPA requirements, as well as for CE marking and FDA 510(k) clearances in international markets.

Third-Party Conformity Assessment

Independent testing laboratories, notified bodies, and certification agencies rely on these standardized test programs to verify supplier declarations and support tender qualifications and export documentation such as certificates of free sale.

Hospital Procurement and Post-Market Surveillance

Hospitals and centralized procurement agencies commission targeted testing, such as flow rate, tightness, and endotoxin checks, to verify incoming product quality, while regulators conduct post-market sampling and adverse event investigations using the same methods.

FAQ

Which standards govern single-use infusion device testing?

The primary standards are GB 8368 for infusion sets, GB 8369 for transfusion sets, GB 15810 and GB 15811 for syringes and needles, GB/T 14233 for chemical and biological test methods, GB/T 16886 (ISO 10993) for biological evaluation, and ISO 8536-4, ISO 1135-4, and ISO 7886-1 for international equivalence.

Is biological testing required for every batch?

No. Biological evaluation is primarily a type test and risk management activity. Routine batch release typically relies on physical performance, chemical indicators, and documented sterilization validation, with biological testing repeated when materials, suppliers, or processes change.

How are ethylene oxide residuals controlled?

Devices sterilized with ethylene oxide undergo validated aeration cycles, and residual ethylene oxide and ethylene chlorohydrin are quantified by headspace gas chromatography against the limits in GB/T 16886.7 and ISO 10993-7.

How many samples are needed for a full test program?

Sample quantities depend on the device type and the number of test items, since chemical extraction, sterility, and biological tests each consume dedicated units. Testing laboratories typically provide a sample requirement list based on the applied sampling plan.

How long does complete type testing take?

Physical and chemical testing generally completes within a few weeks, while full biological programs including cytotoxicity, sensitization, and hemolysis may require four to eight weeks or longer depending on test selection and laboratory capacity.